Successful Product Approvals
Members of the InSite QA team have contributed to the successful approvals of the following products:
- Proscar® (Benign Prostatic Hyperplasia, 1992)
- ICON® Strep-B Diagnostic Test(TM) (Streptococcus b, 1993)
- ICON II® HCG Test(TM) (Pregnancy, 1993)
- Fosamax® (Osteoporosis, 29SEP1995)
- Betaseron® (Multiple Sclerosis, 17MAY1996)
- Zocor® (Cholesterol lowering agent, NOV1997)
- Tobi® (Cystic Fibrosis, 21NOV1997)
- Proleukin® (Renal Cell Carcinoma, Melanoma, JAN1998)
- Tricelluvax® (Diphtheria, Tetanus and Acellular Pertussis, EU 1999)
- Tamiflu® (Influenza, 27OCT1999)
- Fluad® (Influenza Vaccine, EU 24MAY2000)
- Fluvirin® (Influenza Vaccine, 21JUL2006)
- Viread® (HIV, 12AUG2008)
- Qutenza® (Postherpetic Neuralgia, 10JUN2009)
- CIMZIA® (Crohn’s Disease and Rheumatoid Arthritis, 14MAY2009)
- Cayston® (Cystic Fibrosis, 23FEB2010)
- Provenge® (Prostate Cancer, 29APR2010)
- Teflaro™ (Community-Acquired Bacterial Pneumonia (CABP) and Acute Bacterial Skin and Skin Structure Infection (ABSSSI), 29OCT2010)
Esbriet® (pirfenidone) for Idiopathic Pulmonary Fibrosis (IPF) – pending